Diagnostic Performance of an Aspergillus-specific Nested PCR Assay in Cerebrospinal Fluid Samples

• Conditions: Focus: Immunocompromised Individuals at High Risk of Aqcuiring Invasive Aspergillosis

• Registration Number: NCT01614145
• Lead Sponsor: Heidelberg University

Brief Summary

Multicentre, diagnostic study evaluating the performance of an aspergillus-specific PCR in cerebrospinal fluid samples of immunocompromised patients for identification of central nervous system aspergillosis.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-09
• Study First Submitted: 2012-06-05
• Study First Submitted QC: 2012-06-05
• Study First Posted: 2012-06-07
• Status Verified: 2020-04
• Last Update Submitted: 2020-04-17
• Last Update Posted: 2020-04-20
• Primary Completion: 2020-12
• Study Completion: 2020-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Host factors
• Informed consent

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Test sensitivity	one year

Trial Locations

Locations (3)

Freiburg University Hospital; 🇩🇪 Freiburg, Baden-Würrtemberg, Germany

Frankfurt (Oder) General Hospital; 🇩🇪 Frankfurt (Oder), Brandenburg, Germany

Mannheim University Hospital; 🇩🇪 Mannheim, Baden-Würrtemberg, Germany